CME Group Inc. $CME Shares Bought by Bessemer Group Inc.

Bessemer Group Inc. lifted its holdings in CME Group Inc. (NASDAQ:CME) by 0.6% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 916,457 shares of the financial services provider’s stock after purchasing an additional 5,049 shares during the period. Bessemer Group Inc. owned about 0.25% of CME Group worth $252,593,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in the business. GoalVest Advisory LLC grew its stake in shares of CME Group by 67.6% in the 2nd quarter. GoalVest Advisory LLC now owns 439 shares of the financial services provider’s stock worth $121,000 after purchasing an additional 177 shares during the last quarter. Solstein Capital LLC grew its stake in shares of CME Group by 35.0% in the 2nd quarter. Solstein Capital LLC now owns 1,108 shares of the financial services provider’s stock worth $305,000 after purchasing an additional 287 shares during the last quarter. Envestnet Asset Management Inc. grew its stake in shares of CME Group by 2.6% in the 2nd quarter. Envestnet Asset Management Inc. now owns 584,815 shares of the financial services provider’s stock worth $161,187,000 after purchasing an additional 14,609 shares during the last quarter. Chilton Capital Management LLC acquired a new position in shares of CME Group in the 2nd quarter worth approximately $105,000. Finally, Resonant Capital Advisors LLC grew its stake in shares of CME Group by 46.7% in the 2nd quarter. Resonant Capital Advisors LLC now owns 1,166 shares of the financial services provider’s stock worth $321,000 after purchasing an additional 371 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Performance

CME stock opened at $269.54 on Monday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market cap of $97.14 billion, a P/E ratio of 26.12, a P/E/G ratio of 6.65 and a beta of 0.41. The firm has a 50 day simple moving average of $266.47 and a 200 day simple moving average of $271.90. CME Group Inc. has a 52 week low of $213.94 and a 52 week high of $290.79.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.63 by $0.05. The business had revenue of $1.54 billion during the quarter, compared to analysts’ expectations of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The firm’s quarterly revenue was down 3.0% compared to the same quarter last year. During the same period last year, the company posted $2.68 earnings per share. Research analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 48.45%.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the stock. The Goldman Sachs Group lifted their price objective on shares of CME Group from $262.00 to $263.00 and gave the stock a “sell” rating in a research note on Thursday. Raymond James Financial dropped their target price on shares of CME Group from $309.00 to $307.00 and set an “outperform” rating on the stock in a research report on Monday, October 13th. Morgan Stanley lifted their target price on shares of CME Group from $312.00 to $314.00 and gave the stock an “overweight” rating in a research report on Thursday. Wall Street Zen downgraded shares of CME Group from a “hold” rating to a “sell” rating in a research report on Sunday, July 13th. Finally, JPMorgan Chase & Co. lifted their target price on shares of CME Group from $252.00 to $256.00 and gave the stock an “underweight” rating in a research report on Tuesday, October 14th. Eight investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $284.53.

Insider Activity at CME Group

In related news, General Counsel Jonathan L. Marcus sold 392 shares of the firm’s stock in a transaction that occurred on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the sale, the general counsel directly owned 7,851 shares in the company, valued at approximately $2,056,962. This trade represents a 4.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Sunil Cutinho sold 11,896 shares of the firm’s stock in a transaction that occurred on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the sale, the insider owned 17,440 shares of the company’s stock, valued at approximately $4,734,436.80. This represents a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 13,043 shares of company stock valued at $3,527,956. 0.30% of the stock is owned by company insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.